Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?

NCT03227562 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Stopped not enough patient

Conditions

Anxiety State

Interventions

DRUG: RisperiDONE 0.5 MG

Sponsor

Marion Trousselard